S, P., M, H., K, P., P, V., G, L., I, A., . . . E, S. (2022). Assessment of myocardial salvage in patients with STEMI undergoing thrombolysis: Ticagrelor versus clopidogrel. BMC cardiovascular disorders, 22(1), 301. https://doi.org/10.1186/s12872-022-02735-1
Chicago Style (17th ed.) CitationS, Petousis, Hamilos M, Pagonidis K, Vardas P, Lazopoulos G, Anastasiou I, Zacharis E, Kochiadakis G, and Skalidis E. "Assessment of Myocardial Salvage in Patients with STEMI Undergoing Thrombolysis: Ticagrelor Versus Clopidogrel." BMC Cardiovascular Disorders 22, no. 1 (2022): 301. https://doi.org/10.1186/s12872-022-02735-1.
MLA (9th ed.) CitationS, Petousis, et al. "Assessment of Myocardial Salvage in Patients with STEMI Undergoing Thrombolysis: Ticagrelor Versus Clopidogrel." BMC Cardiovascular Disorders, vol. 22, no. 1, 2022, p. 301, https://doi.org/10.1186/s12872-022-02735-1.